Neuronetics, Inc. (STIM)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Revenue
- 149,157,000 99.2%
- Net income
- -38,998,000
- Gross profit
- 72,308,000
- Operating income
- -31,436,000
- Earnings per share
- -0.59
- R&D expense
- 6,584,000
Growth and profitability
- Gross margin
- 48.48
- Operating margin
- -21.08
- Net margin
- -26.15
- Return on equity
- -174.27
- Return on assets
- -27.55
- Free cash flow margin
- -14.20
Balance sheet
- Total assets
- 141,551,000
- Total liabilities
- 115,311,000
- Shareholders' equity
- 22,378,000
- Cash and equivalents
- 28,134,000
- Debt
- 65,807,000
- Net debt
- 37,673,000
- Current ratio
- 2.02
- Debt to equity
- 2.94
Cash flow and ratios
- Operating cash flow
- -20,374,000
- Free cash flow
- -21,175,000
Shareholder returns
- Shares outstanding
- 77,728,311
- Book value per share
- 0.29
Company information
- Headquarters
- Malvern, PA
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Surgical & Medical Instruments & Apparatus
Fiscal year end: · Source: SEC EDGAR
Neuronetics, Inc. trades on NASDAQ under the ticker symbol STIM. This page brings together its price chart, company profile, key financial figures and technical indicators.